search
Back to results

Effect of Exercise and Weight Loss on Cardiovascular Health (Heart Health)

Primary Purpose

Cardiovascular Disease, Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Behavioral weight loss intervention
Diet Plus Moderate Exercise
Diet Plus High Exercise
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiovascular Disease focused on measuring cardiovascular disease, obesity, exercise

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 18-55 years of age.
  • Body mass index (BMI) between 25.0 to <40.0 kg/m2.
  • Ability to provide informed consent prior to participation in this study.

Exclusion Criteria:

  • Females who are currently pregnant or breastfeeding, or reporting that she is planning a pregnancy within the next 12 months.
  • History of bariatric surgery.
  • Report current medical condition or treatment for a medical condition that could affect body weight. These may include the following: cancer (Note: Persons previously diagnosed with non-melanoma skin cancers, those successfully treated for cancer who have remained disease-free for five years or more would be eligible for participation in this study); diabetes mellitus; hyperthyroidism; inadequately controlled hypothyroidism; chronic renal insufficiency; chronic liver disease; gastrointestinal disorders including ulcerative colitis, Crohn's disease, or malabsorption syndromes; etc.
  • Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e. recent or recurrent DVT).
  • Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of >100 mmHg.
  • Eating disorders that would contraindicate weight loss or physical activity.
  • Alcohol or substance abuse.
  • Currently treated for psychological issues (i.e., depression, bipolar disorder, etc), taking psychotropic medications within the previous 12 months, or hospitalized for depression within the previous 5 years.
  • Report exercise on >3 days per week for >20 minutes per day over the past 3 months. (NOTE: It is important that individuals are sedentary when entering this study to allow for maximal effect of the intervention.)
  • Report weight loss of >5% or participating in a weight reduction diet in the past 3 months.
  • Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance to at least 80 percent of the scheduled intervention sessions and all of the scheduled assessments.

Sites / Locations

  • University of Pittsburgh

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Diet alone

Diet plus Moderate Exercise

Diet Plus High Exercise

Arm Description

Weight loss intervention that focuses only on reducing energy intake of the diet.

Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 150 minutes per week of moderate-intensity exercise.

Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 250-300 minutes per week of moderate-intensity exercise.

Outcomes

Primary Outcome Measures

Change in Left ventricular mass assessed using cardiac MRI
Left ventricular mass will be assessed using cardiac MRI

Secondary Outcome Measures

Change in end-diastolic volume assessed using cardiac MRI
Assessed using cardiac MRI
Change in cardiorespiratory fitness
Measured using a graded exercise test
Change in blood levels of C-Reactive Protein (CRP)
Assessed from a fasting blood sample
Change in body weight
Change in body composition
Measured using dual-energy x-ray absorptiometry (DXA)
Change in regional adiposity
Measured using anthromometry that includes girth measures of the waist and hip
Change in physical activity
Measured using both a wearable device and by questionnaire
Change in energy intake
Assessed using a questionnaire
Change in traditional CVD risk factors (lipids, glucose, insulin)
Measured from a fasting blood sample
Change in resting blood pressure

Full Information

First Posted
December 22, 2011
Last Updated
July 24, 2017
Sponsor
University of Pittsburgh
search

1. Study Identification

Unique Protocol Identification Number
NCT01500356
Brief Title
Effect of Exercise and Weight Loss on Cardiovascular Health
Acronym
Heart Health
Official Title
Effect of Exercise and Weight Loss on Cardiovascular Health
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
December 13, 2011 (Actual)
Primary Completion Date
June 30, 2016 (Actual)
Study Completion Date
June 30, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity [moderate physical activity (MOD-PA) = 150 min/wk] versus a higher dose of physical activity [high physical activity (HIGH-PA) = 250 min/wk] in the context of a comprehensive behavioral weight loss program that a includes a reduction in energy intake measures of cardiovascular function using cardiac MRI and biomarkers of vascular disease risk. Each of these exercise doses will be compared independently to a Diet Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for a period of 12 months. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume, aortic distensibility), inflammatory markers (CRP and TNFα) and selected adipocytokines (adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids, glucose, insulin, blood pressure). Additional secondary analyses will allow for examination of the effects of physical activity independent of weight change on the primary and secondary outcomes.
Detailed Description
Current estimates indicate that in excess of 65 percent of adults in the United States are overweight (BMI >25.0 kg/m2) with at least 30 percent of adults classified as obese (BMI >30 kg/m2). Overweight and obesity have been linked to numerous chronic conditions including cardiovascular disease. The application of cardiac MRI (CMRI) allows for direct measurement of the cardiac structure, and left ventricular mass (LVM) assessed by CMRI has been shown to be predictive of cardiovascular disease. Recent studies have shown that LVM is decreased with weight loss; however, there is a lack of information on the added benefit of physical activity to weight loss on these direct measures of cardiovascular structure and function. Thus, consistent with PA-09-243, this study will examine the effect of two recommended doses of physical activity combined with a dietary intervention on changes in the proposed outcomes of cardiovascular disease risk in overweight adults. The primary aim of this study is to examine the effect of the consensus public health recommended level of physical activity [moderate physical activity (MOD-PA) = 150 min/wk] versus a higher dose of physical activity [high physical activity (HIGH-PA) = 250 min/wk] in the context of a comprehensive behavioral weight loss program that a includes a reduction in energy intake measures of cardiovascular function using cardiac MRI and biomarkers of vascular disease risk. Each of these exercise doses will be compared independently to a Diet Only group intervention on the proposed primary and secondary outcomes, with MOD-PA also compared to HIGH-PA. This study involves the recruitment of 390 overweight and obese adults who will be randomly assigned to one of the above conditions (Diet Only, MOD-PA, HIGH-PA) for a period of 12 months. The primary outcome is LVM measured by cardiac MRI. Secondary outcomes include additional cardiac MRI measures (aortic pulse wave velocity, end diastolic volume, aortic distensibility), inflammatory markers (CRP and TNFα) and selected adipocytokines (adiponectin) as biomarkers of risk related to vascular outcomes, body weight, body composition, and cardiorespiratory fitness, and traditional CVD risk factors (lipids, glucose, insulin, blood pressure). Additional secondary analyses will allow for examination of the effects of physical activity independent of weight change on the primary and secondary outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Disease, Obesity
Keywords
cardiovascular disease, obesity, exercise

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
383 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diet alone
Arm Type
Experimental
Arm Description
Weight loss intervention that focuses only on reducing energy intake of the diet.
Arm Title
Diet plus Moderate Exercise
Arm Type
Experimental
Arm Description
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 150 minutes per week of moderate-intensity exercise.
Arm Title
Diet Plus High Exercise
Arm Type
Experimental
Arm Description
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 250-300 minutes per week of moderate-intensity exercise.
Intervention Type
Behavioral
Intervention Name(s)
Behavioral weight loss intervention
Intervention Description
Weight loss intervention that focuses on reducing energy intake.
Intervention Type
Behavioral
Intervention Name(s)
Diet Plus Moderate Exercise
Intervention Description
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 150 minutes per week of moderate-intensity exercise.
Intervention Type
Behavioral
Intervention Name(s)
Diet Plus High Exercise
Intervention Description
Weight loss intervention that involve an energy restricted diet (identical to the Diet Alone arm) plus the inclusion of 250-300 minutes per week of moderate-intensity exercise.
Primary Outcome Measure Information:
Title
Change in Left ventricular mass assessed using cardiac MRI
Description
Left ventricular mass will be assessed using cardiac MRI
Time Frame
Baseline (0 months) and 12 months
Secondary Outcome Measure Information:
Title
Change in end-diastolic volume assessed using cardiac MRI
Description
Assessed using cardiac MRI
Time Frame
baseline (0 months) and 12 months
Title
Change in cardiorespiratory fitness
Description
Measured using a graded exercise test
Time Frame
baseline (0 months) 6 months, and 12 months
Title
Change in blood levels of C-Reactive Protein (CRP)
Description
Assessed from a fasting blood sample
Time Frame
baseline (0 months), 6 months, and 12 months
Title
Change in body weight
Time Frame
baseline (0 months), 6 months, and 12 months
Title
Change in body composition
Description
Measured using dual-energy x-ray absorptiometry (DXA)
Time Frame
baseline (0 months), 6 months, and 12 months
Title
Change in regional adiposity
Description
Measured using anthromometry that includes girth measures of the waist and hip
Time Frame
baseline (0 months), 6 months, 12 months
Title
Change in physical activity
Description
Measured using both a wearable device and by questionnaire
Time Frame
baseline (0 months), 6 months, 12 months
Title
Change in energy intake
Description
Assessed using a questionnaire
Time Frame
baseline (0 months), 6 months, 12 months
Title
Change in traditional CVD risk factors (lipids, glucose, insulin)
Description
Measured from a fasting blood sample
Time Frame
baseline (0 months), 6 months, 12 months
Title
Change in resting blood pressure
Time Frame
baseline (0 months), 6 months, 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18-55 years of age. Body mass index (BMI) between 25.0 to <40.0 kg/m2. Ability to provide informed consent prior to participation in this study. Exclusion Criteria: Females who are currently pregnant or breastfeeding, or reporting that she is planning a pregnancy within the next 12 months. History of bariatric surgery. Report current medical condition or treatment for a medical condition that could affect body weight. These may include the following: cancer (Note: Persons previously diagnosed with non-melanoma skin cancers, those successfully treated for cancer who have remained disease-free for five years or more would be eligible for participation in this study); diabetes mellitus; hyperthyroidism; inadequately controlled hypothyroidism; chronic renal insufficiency; chronic liver disease; gastrointestinal disorders including ulcerative colitis, Crohn's disease, or malabsorption syndromes; etc. Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e. recent or recurrent DVT). Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of >100 mmHg. Eating disorders that would contraindicate weight loss or physical activity. Alcohol or substance abuse. Currently treated for psychological issues (i.e., depression, bipolar disorder, etc), taking psychotropic medications within the previous 12 months, or hospitalized for depression within the previous 5 years. Report exercise on >3 days per week for >20 minutes per day over the past 3 months. (NOTE: It is important that individuals are sedentary when entering this study to allow for maximal effect of the intervention.) Report weight loss of >5% or participating in a weight reduction diet in the past 3 months. Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance to at least 80 percent of the scheduled intervention sessions and all of the scheduled assessments.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John M. Jakicic, PhD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15260
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
35470972
Citation
Jakicic JM, Rogers RJ, Lang W, Gibbs BB, Yuan N, Fridman Y, Schelbert EB. Impact of weight loss with diet or diet plus physical activity on cardiac magnetic resonance imaging and cardiovascular disease risk factors: Heart Health Study randomized trial. Obesity (Silver Spring). 2022 May;30(5):1039-1056. doi: 10.1002/oby.23412.
Results Reference
derived

Learn more about this trial

Effect of Exercise and Weight Loss on Cardiovascular Health

We'll reach out to this number within 24 hrs